Appropriateness and inappropriate medication predictors of stress ulcer prophylaxis in the intensive care unit

Appropriateness and inappropriate medication predictors of stress ulcer prophylaxis in the intensive care unit

IntroductionPreventive drugs for stress ulcers are widely and unreasonably used in the Intensive Care Unit (ICU). This study aims to examine the appropriate utilization of medications for stress ulcer prophylaxis (SUP) and identify factors that contribute to the inappropriate use of these medication...

Full description

Saved in:

Bibliographic Details
Main Authors:	Pan Zhang, Siyang Wang, Tingting Zhi, Naobei Ye, Haonan Sun, Xingyu Qin, Shuhan Xu, Ruiqin Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Pharmacology
Subjects:	stress ulcer prophylaxis intensive care unit rational drug use proton pump inhibitors operating characteristic curve
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1401335/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pharmaceutical hemostasis at peptic ulcer bleeding: state-of-the-art and perspectives
by: A. A. Schegolev, et al.
Published: (2013-07-01)

Vonoprazan in the management of erosive oesophagitis and peptic ulcer-induced medication: a systematic review
by: Décio Chinzon, et al.
Published: (2021-12-01)

Inappropriate prescribing of drugs for peptic ulcer and gastro-esophageal reflux disease remains a matter of concern: Results from the LAPTOP-PPI cluster randomized trial
by: Manuela Casula, et al.
Published: (2025-01-01)

Diagnosis and Treatment of Peptic Ulcer in Adults (Clinical Guidelines of the Russian Gastroenterological Association, Russian Society of Colorectal Surgeons and the Russian Endoscopic Society)
by: V. T. Ivashkin, et al.
Published: (2020-04-01)

Patterns of outpatient proton‒pump inhibitors use among older adults in a duplicative health system: comparing public and private prescribing
by: Sónia Romano, et al.
Published: (2025-01-01)

Antisecretory treatment efficacy by proton pump inhibitors at gastroduodenal ulcer bleedings
by: M. A. Evseyev, et al.
Published: (2010-06-01)

Predictive Factors Associated with Inappropriate Intravenous Proton Pump Inhibitors Use in Hospitalized Patients: A Case-Control Study
by: Niveen Khoury, et al.
Published: (2024-12-01)

Current Trends in Treatment for Acid-Dependent Diseases: Clinical Efficacy and Safety of Rabeprazole
by: O. D. Lopina, et al.
Published: (2021-12-01)

Consultations for HIV post-exposure prophylaxis before and after health insurance coverage of pre-exposure prophylaxis to a university-based emergency department in Germany
by: Lennert Böhm, et al.
Published: (2023-12-01)

Risk Factors and Prevention of Upper Gastrointestinal Complications Associated with Nonsteroidal Anti-Inflammatory Drugs
by: N. V. Bakulina, et al.
Published: (2025-02-01)

Gastroesophageal reflux disease, resistant to proton pump inhibitors
by: V. O. Kaybysheva, et al.
Published: (2011-06-01)

<i>H. pylori</i> eradication therapy for patients receiving nonsteroid antiinflammatory drugs
by: V. T. Ivashkin, et al.
Published: (2012-11-01)

Predictors of infliximab efficacy in patients with severe attack of ulcerative colitis
by: A. O. Golovenko, et al.
Published: (2013-10-01)

Topical Rifamycin Prophylaxis in Gynecological and Obstetric Surgery
by: Nahit Ata, et al.
Published: (2022-03-01)

Change in Symptoms and Mucosal Findings after Proton Pump Inhibitor in Patients with Laryngopharyngeal Reflux
by: Min Woo Park, et al.
Published: (2025-01-01)

Which is the best choice for Helicobacter pylori eradication? Dual therapy or quadruple therapy?
by: Elif Gram Bacaksız, et al.
Published: (2022-05-01)

Proton pump inhibitor leaflets: Is there information on deprescribing?
by: Marcus Vinícius Lopes Campos, et al.
Published: (2025-01-01)

Modern aspects of diagnostics and treatment of <i>H. pylori</i> infection from standpoint of stomach cancer prophylaxis
by: A. A. Sheptulin, et al.
Published: (2015-03-01)

The importance of dietary magnesium sulphate for prophylaxis of parturient paresis in cow with high milk production
by: M. Ali Bostancı, et al.

Proportion of HIV exposed infants aged 0-6 months that missed nevirapine prophylaxis in Mulago National Referral Hospital, Uganda: a cross-sectional study
by: Nasambu Hellen, et al.
Published: (2024-07-01)

Proton pump inhibitors enhance chemosensitivity, promote apoptosis, and suppress migration of breast cancer cells
by: Ihraiz Worood G., et al.
Published: (2020-06-01)

Contemporary Approaches to the Treatment of Gastroesophageal Reflux Disease
by: Boris D. Starostin
Published: (2019-03-01)

Deprescribing and Optimal Selection of Proton Pump Inhibitors (Contributions of the 26th United Russian Gastroenterology Week)
by: V. T. Ivashkin, et al.
Published: (2020-12-01)

A global review of national guidelines of post‐exposure prophylaxis for the prevention of HIV
by: Marcus Maisano, et al.
Published: (2025-01-01)

Efficacy of Extended Antibiotic Prophylaxis with Azithromycin in Cesarean Sections
by: Sumangali Thirunavukkarausu, et al.
Published: (2024-12-01)

A persona-based exploration of rabies post-exposure prophylaxis seeking behavior and its implication for communication strategic planning: Evidence from Thailand
by: Jitjayang Yamabhai, et al.
Published: (2025-06-01)

Safety Evaluation of the Novel Cocktail of Monoclonal Antibodies for Postexposure Prophylaxis in Category III Animal Exposures
by: Ravish Haradanahalli Shankaraiah, et al.
Published: (2024-12-01)

PERIOPERATIVE PROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN ROUTINE ONCOSURGERY
by: V. E. Khoronenko, et al.
Published: (2016-12-01)

New perspectives in the management of acute pancreatitis – focus on antibiotic prophylaxis, management of necrosis and COVID-19 implications
by: Aleksandra Woźniak, et al.
Published: (2025-02-01)

Efficacy and Safety of Dual Delayed-Release Formulation of Esomeprazole in Patients with Gastroesophageal Reflux Disease: A Multicenter, Prospective, Observational Study
by: Hyun Lim, et al.
Published: (2025-01-01)

Comparison of clinical and pharmacodynamic features of proton pump inhibitors efficacy in gastroesophageal reflux disease
by: O. A. Storonova, et al.
Published: (2015-12-01)

Increase in treatment compliance reveals new options of treatment of gastroesophageal reflux disease
by: Yu. V. Yevsyutina, et al.
Published: (2015-05-01)

Clinical Guidelines of the Russian Gastroenterological Association on the Diagnostics and Treatment of Eosinophilic Esophagitis
by: V. T. Ivashkin, et al.
Published: (2019-01-01)

Potassium-competitive acid blockers, a new therapeutic class, and their role in acid-related diseases: a narrative review
by: Gerson Domingues, et al.
Published: (2022-08-01)

The role of pH in symptomatic relief and effective treatment of gastroesophageal reflux disease
by: Anita Gąsiorowska
Published: (2017-12-01)

Comparison of two bolus doses of dexmedetomidine for prophylaxis against postoperative nausea and vomiting in highly susceptible patients: A randomized controlled trial
by: Maha Mohamed Ismail Youssef, et al.
Published: (2024-04-01)

The impact of organised educational campaigns on understanding of needle sticks injuries and related post-exposure HIV/AIDS prophylaxis
by: Ram Kumar Garg, et al.
Published: (2025-01-01)

Efficacy and Safety Assessment of Antifungal Prophylaxis with Posaconazole Using Therapeutic Drug Monitoring in Pediatric Patients with Oncohematological Disorders—A Single-Centre Study
by: Karolina Liszka, et al.
Published: (2025-01-01)

The latest therapeutic reports on short-term and long-term prophylaxis in the treatment of hereditary angioedema
by: Maciej Kozłowski, et al.
Published: (2024-02-01)

Human Immunodeficiency Virus Preexposure Prophylaxis Awareness and Acceptability among Men Who Have Sex with Men and Transgender Persons in India: Systematic Review and Meta-analysis
by: Adhish Kumar Sethi, et al.
Published: (2024-04-01)